Friday, 20 Jul 2018

You are here

ACR17 Good News – Ankylosing Spondylitis and Spondyloarthritis

The following is a collection of AS/SpA-specific mentions culled from RheumNow's coverage of the Annual ACR 2017 meeting in San Diego.

Visit our RheumNow annual meeting site to read our gout content -

Specific items:

  • Bone marrow oedema in sacroiliac joints is common (30-40%) in young athletes and is most frequent in the posterior lower ilium.  Weber et al
  • Only 9-14% people with chronic backache see a rheumatologist 
  • Increased risk of CVA, but not for MI, in AS pts. Abstract #2972
  • Low mean change in radiographic change after 4 years of Secukinumab treatment in AS, Braun 
  • Smoking is associated with higher disease activity and worse quality of life in SpA patients. Abstract #2506
  • IBD is assoc.tih more severe SpA. Occurs w/ rate of 0.7/100 patient-yrs/ 5 yrs in DESIR cohort. Abstract #2512
  • FUTURE5: Cosentyx clinically &radiographically superior to PBO. mTSS non-progression rate = 88% for Cosentyx vs 73% PBO #L17 #acr17
  • Dheodar et al-Large study on impact of TNFi on xtra art. comorbidities in AS. Abstract #1527
  • Don't discount spondyloarthropathy in pts >45yo, especially if pt has psoriasis or inflammatory back pain. Abstract #2037
  • Low DMARD use on AS pts on chronic opioids Abstract #1548
  • Significant reduction in immunosuppression load on uveitis pts with long term ADA use. Abstract #1115
  • Abstract #1881  Uveitis & scleritis common in AI disease. Lack of consensus on workup guidelines; calls for Ophth/Rheum collaboration
  • Gut-derived TNF: Connection Between Crohn’s and SpA and Sacroiliitis
  • Landewe Plenary session: Stopping adalimumab in nrAxSpA patients in sustained remission leads to flare after 8-12 weeks in 53%
  • Plenary Abstract #1787 Landawe presents Atlas 5 study, continuation of ADA is assoc with significantly less flares in nr-AxSpA
  • uSpA pts are younger, more likely +HLA-B27, and higher CRP than nrSpA pts. Abstract  #1506
  • Chronic reactive arthritis due to chlamydia could be treated with longterm antibiotics with up to 70% achieving remission
  • Reactive Arthritis 
  •  The Red Eye in the Rheumatology Patient
  • Higher risk of VTE on patients hospitalized with SpA, comparable with that of malignancy>OA Abstract #879
  • There was 12% progression in 2yrs to AS from nrAxSpA
  • 53% risk of VTE and 62% DVT in AS compared to general population. Confounders not measured Abstract #3S078
  • Higher prevalence of venous thrombosis in SpA admissions- Inflammation driven thrombosis & NSAIDs to blame? Dilli Poudel Abstract #879
  • Higher risk of VTE on patients hospitalized with SpA, comparable with that of malignancy, but > than OA Abstract #879
  • Abstract #578 Of 10 Biomarkers, combo of 2 showed small value added in terms of rad.progression in AxSpA
  • Abstract #593  EarlyAxSpA DESIR 5 year data showed low rates of structural progression-SI fatty lesions
  • Dr L Gensler at #ACR17: says tobacco use decreases efficacy of TNF inhibitors
  • Dr L Gensler: UK database 1 out of 4 pts with ank spond will have had uveitis after 20 years of AS
  • Dr L Gensler: EDS and JHS can mimic inflammatory arthritis and spondyloarthritis
  • Dr L Gensler: X-rays unreliable to detect sacroilitis; limited CT is gold std. MRI is better
  • In the evaluation of axial spondyloarthropathies MRI without Gad and CRP over ESR are preferred. (LianneGensler)
  • DDX of sacroiliitis: Osteitis condensans ilii -CRP normal, multiparous women with back pain, even with subtle bone marrow edema.

AS/SpA Videos

Dr. Julio Gonzalez: Psoriatic Arthritis and Axial Spondyloarthropathy Studies


Dr. Rachel Tate: Gender Bias in AS 


Dr. Rachel Tate: Adalimumab and Disease Remission in non-Radiographic Axial SpA



Dr. David Borenstein: Back Pain

The author has received research/grant financial support on this subject
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

Liver Disease Increased in Psoriasis

An observational case-control study has shown that psoriasis is associated with an increased prevalence of nonalcoholic fatty liver disease (NAFLD).

A single center, outpatient dermatology clinic studied 151 patients with psoriasis and 51 control subjects with ultrasonography to diagnose NAFLD.

Best of 2017: Cause of Death in Ankylosing Spondylitis

A French population based study of ankylosing spondylitis (AS) was report in the Journal of Rheumatology.

They analyzed the death certificates and cause of death in 2940 AS patients over 3 different decades (1969-78; 1979-99; 2000-2009).

The mortality rate of AS remained stable over time.

Ixekizumab Effective in Ankylosing Spondylitis

Eli Lilly announced today the results of the COAST-W trial showing that ixekizumab (Taltz) was effective in a Phase 3 study Ankylosing Spondylitis (AS) patients who had an inadequate response or intolerance to tumor necrosis factor (TNFi) inhibitor therapy.

NPF Dietary Recommendations for Psoriatic Disease

The National Psoriasis Foundation has released dietary recommendations for adults with psoriasis and psoriatic arthritis, based on a systematic review of the current literature, with the strongest focus on weight reduction for those who are overweight or obese.

Enthesitis in PsA: A New Focus of Treatment?

Patients with psoriatic arthritis (PsA) whose disease manifestations include enthesitis showed significantly greater responses to interleukin (IL)-23 inhibition than to blocking tumor necrosis factor (TNF), suggesting the possibility that treatment decisions in the future might be guided by specific cytokine targeting.